Human Mixact H 30/70 Injection Substitute

Human Mixact H 30/70 Injection is a combination of two drugs, namely: Human insulin (a short-acting type of insulin) and Insulin isophane (intermediate-acting). Human Mixact H 30/70 Injection is used for the treatment of both type 1 and type 2 diabetes mellitus. Human Mixact H 30/70 Injection suppresses the production of sugar in the liver and facilitates the reuptake of sugar in the fat and muscle cells, thereby Human Mixact H 30/70 Injection ensures rapid and consistent sugar control.  Human Mixact H 30/70 Injection helps in improving the glycaemic control which in turn decreases the risk of progression of diabetes complications like damage of retina (retinopathy), damage of kidney (nephropathy), damage of nerve cells (neuropathy), delayed wound healing, and diabetic foot ulcer.